BALOUCH THERAPY APS
CVR 45246388 · Private limited company (ApS) · Active · Medium risk
BALOUCH THERAPY APS is a Private limited company (ApS), founded on , based in Vedbæk. The company is registered in the industry psykologisk og psykoterapeutisk rådgivning. Our model estimates a bankruptcy risk of 1.6% over the next 12 months, which is 1.1 times the average for Danish companies. 1 annual report has been published. The latest annual report (31 Dec 2025) shows equity of DKK 16k and a net result of DKK -24k. CEO: Mersedeh Balouch-Celikcan.
Bankruptcy risk for BALOUCH THERAPY APS
1.1 × the average (1.41%) · higher risk than 79% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 45246388
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (1 years)
- Address
- Kong Georgsvej 14
2950 Vedbæk - Municipality
- Hørsholm
- Industry
- Psykologisk og psykoterapeutisk rådgivning (869300)
Bankruptcies in the industry: Praktiserende tandlæger - Share capital
- DKK 40k
- Auditor
- Vedbæk Revision, Registreret Revisionsfirma FSR
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 1 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 15.5% |
| Current ratio | 118% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 0 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 |
|---|---|
| Gross profit | DKK 829k |
| Net profit | DKK -24k |
| Equity | DKK 16k |
| Total assets | DKK 102k |
| Cash | DKK 3,016 |
| Short-term debt | DKK 86k |
| Avg. employees | 1 |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Vedbæk Revision, Registreret Revisionsfirma FSR.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 27 Nov 2024 – 31 Dec 2025 | 180 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Mersedeh Balouch-Celikcan | Current | |
| Owner (100%) | Mersedeh Balouch-Celikcan | Current | |
| Founder | Mersedeh Balouch-Celikcan | Current |
The CEOs' other companies
Mersedeh Balouch-Celikcan – 1 other companies
- CUBII ApS Opløst
Address history (0 moves)
| Kong Georgsvej 14, 2950 Vedbæk |
Similar companies in Hørsholm
- Kognitiv Center Nordsjælland ved Lital Cohen ApS Hørsholm
- Kognitiv Center Nordsjælland ved Signe Malmose ApS Hørsholm
- Intuitiv Rådgivning ApS Hørsholm
- Psykologisk Rådgivning - Kommunikation & Udvikling ApS Rungsted Kyst
- KANT PSYK ApS Hørsholm
- NAYBERG ApS Rungsted Kyst
- PSYKOLOG SUSANNE BARGMANN ApS Hørsholm
Questions and answers about BALOUCH THERAPY APS
Has BALOUCH THERAPY APS gone bankrupt?
No, BALOUCH THERAPY APS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of BALOUCH THERAPY APS?
Our model estimates a bankruptcy risk of 1.6% over the next 12 months (medium risk), which is 1.1 times the average for Danish companies.
Who is the CEO of BALOUCH THERAPY APS?
Mersedeh Balouch-Celikcan is the CEO of BALOUCH THERAPY APS.
Who is the auditor of BALOUCH THERAPY APS?
BALOUCH THERAPY APS most recently used Vedbæk Revision, Registreret Revisionsfirma FSR.
When was BALOUCH THERAPY APS founded?
BALOUCH THERAPY APS was founded on 27 November 2024.
What is the equity of BALOUCH THERAPY APS?
Equity was DKK 16k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.